Recent Advances in Primary and Secondary Prevention of Atherosclerotic Stroke

다국어 초록 (Multilingual Abstract)

Atherosclerosis is a major cause of ischemic stroke that can be effectively prevented with appropriate lifestyle modifications and control of cardiovascular risk factors. Medical advances in recent years along with aggressive cardiovascular risk factor modifications have resulted in decreased recurrence rates of atherosclerotic stroke. Non-statin lipid-lowering molecules have recently shown clinical benefit and are recommended for very high-risk patients to reduce their risk of stroke. Aggressive hypertension treatment is crucial to reduce atherosclerotic stroke risk.
Advances in antithrombotic treatments include combinations of antiplatelets and new antiplatelet agents in the acute phase post-stroke, which carries a high risk of recurrence. Intensive medical treatment has also limited the indications for carotid interventions, especially for asymptomatic disease. Intracranial atherosclerotic disease may provoke stroke through various mechanisms; it is increasingly recognized as a cause of ischemic stroke with advanced imaging and is best managed with lifestyle modifications and medical therapy. The diagnostic search for the vulnerable culprit atherosclerotic plaque is an area of intense research, from the level of the intracranial arteries to that of the aortic arch. Ultrasonography and novel magnetic resonance imaging techniques (high-resolution vessel-wall imaging) may assist in the identification of vulnerable atherosclerotic plaques as the underlying cause in cryptogenic or misdiagnosed non-atherosclerotic ischemic stroke. Vertebrobasilar atherosclerotic disease is less common than carotid artery disease; thus, high-quality data on effective prevention strategies are scarcer. However, aggressive medical treatment is also the gold standard to reduce cerebrovascular disease located in posterior circulation.

참고문헌 (Reference)

1 Naylor AR, "Why is the management of asymptomatic carotid disease so controversial?" 13 : 34-43, 2015

2 Stromberg S, "Very urgent carotid endarterectomy confers increased procedural risk" 43 : 1331-1335, 2012

3 Al-Ali F, "Vertebral artery ostium atherosclerotic plaque as a potential source of posterior circulation ischemic stroke: result from borgess medical center vertebral artery ostium stenting registry" 42 : 2544-2549, 2011

4 Mitusch R, "Vascular events during follow-up in patients with aortic arch atherosclerosis" 28 : 36-39, 1997

5 Brinjikji W, "Ultrasound characteristics of symptomatic carotid plaques: a systematic review and metaanalysis" 40 : 165-174, 2015

6 Geroulakos G, "Ultrasonographic carotid plaque morphology in predicting stroke risk" 83 : 582-587, 1996

7 Naylor AR, "Time to rethink management strategies in asymptomatic carotid artery disease" 9 : 116-124, 2011

8 Benavente OR, "The secondary prevention of small subcortical strokes (SPS3) study" 6 : 164-175, 2011

9 Kargiotis O, "The role of neurosonology in the diagnosis and management of patients with carotid artery disease: a review" 28 : 239-251, 2018

10 Tsivgoulis G, "The role of colchicine in the prevention of cerebrovascular ischemia" 24 : 668-674, 2018

11 Amarenco P, "The prevalence of ulcerated plaques in the aortic arch in patients with stroke" 326 : 221-225, 1992

12 Catapano A, "The efficacy and safety of ezetimibe coadministered with statin therapy in various patient groups" 8 : 13-41, 2013

13 Wang X, "The effectiveness of dual antiplatelet treatment in acute ischemic stroke patients with intracranial arterial stenosis: a subgroup analysis of CLAIR study" 8 : 663-668, 2013

14 International Stroke Trial Collaborative Group, "The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke" 349 : 1569-1581, 1997

15 Rerkasem K, "Systematic review of randomized controlled trials of patch angioplasty versus primary closure during carotid endarterectomy" 41 : e55-e56, 2010

16 Qureshi AI, "Stroke-free survival and its determinants in patients with symptomatic vertebrobasilar stenosis: a multicenter study" 52 : 1033-1039, 2003

17 Kern R, "Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease" 65 : 859-864, 2005

18 Compter A, "Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial" 14 : 606-614, 2015

19 Brott TG, "Stenting versus endarterectomy for treatment of carotid-artery stenosis" 363 : 11-23, 2010

20 Chimowitz MI, "Stenting versus aggressive medical therapy for intracranial arterial stenosis" 365 : 993-1003, 2011

21 Markus HS, "Stenting for symptomatic vertebral artery stenosis: The Vertebral Artery Ischaemia Stenting Trial" 89 : 1229-1236, 2017

22 Hackam DG, "Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis" 124 : 2233-2242, 2011

23 Lima JA, "Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy" 110 : 2336-2341, 2004

24 Tsivgoulis G, "Statin pretreatment is associated with better outcomes in large artery atherosclerotic stroke" 86 : 1103-1111, 2016

25 Safouris A, "Statin pretreatment and microembolic signals in large artery atherosclerosis" 37 : 1415-1422, 2017

26 Pennlert J, "Socioeconomic status and the risk of stroke recurrence: persisting gaps observed in a nationwide Swedish study 2001 to 2012" 48 : 1518-1523, 2017

27 Kawachi I, "Smoking cessation and decreased risk of stroke in women" 269 : 232-236, 1993

28 Tahara N, "Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography" 48 : 1825-1831, 2006

29 Lau AY, "Significance of good collateral compensation in symptomatic intracranial atherosclerosis" 33 : 517-524, 2012

30 Kobzar G, "Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors" 22 : 338-344, 2011

31 Iemolo F, "Sex differences in carotid plaque and stenosis" 35 : 477-481, 2004

32 Rothwell PM, "Sex difference in the effect of time from symptoms to surgery on benefit from carotid endarterectomy for transient ischemic attack and nondisabling stroke" 35 : 2855-2861, 2004

33 Nicolaides AN, "Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: results from the ACSRS study" 30 : 275-284, 2005

34 Iso H, "Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial" 320 : 904-910, 1989

35 Jung KH, "Secular trends in ischemic stroke characteristics in a rapidly developed country: results from the Korean Stroke Registry Study (secular trends in Korean stroke)" 5 : 327-334, 2012

36 Dormandy JA, "Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomized controlled trial" 366 : 1279-1289, 2005

37 Bogiatzi C, "SPARKLE (Subtypes of Ischaemic Stroke Classification System), incorporating measurement of carotid plaque burden: a new validated tool for the classification of ischemic stroke subtypes" 42 : 243-251, 2014

38 Everett BM, "Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)" 121 : 143-150, 2010

39 Eikelboom JW, "Rivaroxaban with or without aspirin in stable cardiovascular disease" 377 : 1319-1330, 2017

40 Anand SS, "Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial" 2017

41 Mega JL, "Rivaroxaban in patients with a recent acute coronary syndrome" 366 : 9-19, 2012

42 Dhamoon MS, "Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study" 38 : 1752-1758, 2007

43 Ohira T, "Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study" 37 : 2493-2498, 2006

44 Sturgeon JD, "Risk factors for intracerebral hemorrhage in a pooled prospective study" 38 : 2718-2725, 2007

45 Bassand JP, "Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: rationale for comprehensive management of atrial fibrillation" 13 : e0191592-, 2018

46 Kim JS, "Risk factors and stroke mechanisms in atherosclerotic stroke: intracranial compared with extracranial and anterior compared with posterior circulation disease" 43 : 3313-3318, 2012

47 Chaturvedi S, "Risk factor status and vascular events in patients with symptomatic intracranial stenosis" 69 : 2063-2068, 2007

48 Harloff A, "Retrograde embolism from the descending aorta: visualization by multidirectional 3D velocity mapping in cryptogenic stroke" 40 : 1505-1508, 2009

49 Turan TN, "Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis" 115 : 2969-2975, 2007

50 "Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)" 344 : 1383-1389, 1994

51 Waddy SP, "Racial differences in vascular risk factors and outcomes of patients with intracranial atherosclerotic arterial stenosis" 40 : 719-725, 2009

52 Harteveld AA, "Quantitative intracranial atherosclerotic plaque characterization at 7T MRI: an ex vivo study with histologic validation" 37 : 802-810, 2016

53 Kim DE, "Protease imaging of human atheromata captures molecular information of atherosclerosis, complementing anatomic imaging" 30 : 449-456, 2010

54 Janghorbani M, "Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses' Health Study" 30 : 1730-1735, 2007

55 Arenillas JF, "Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: a long-term follow-up transcranial Doppler ultrasound study" 32 : 2898-2904, 2001

56 Estruch R, "Primary prevention of cardiovascular disease with a Mediterranean diet" 368 : 1279-1290, 2013

57 Halliday A, "Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial" 363 : 1491-1502, 2004

58 Kim BJ, "Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial" 17 : 509-518, 2018

59 Hoshino T, "Prevalence of systemic atherosclerosis burdens and overlapping stroke etiologies and their associations with long-term vascular prognosis in stroke with intracranial atherosclerotic disease" 75 : 203-211, 2018

60 Tsivgoulis G, "Prevalence of symptomatic intracranial atherosclerosis in Caucasians: a prospective, multicenter, transcranial Doppler study" 24 : 11-17, 2014

61 Wehrum T, "Prevalence of potential retrograde embolization pathways in the proximal descending aorta in stroke patients and controls" 38 : 410-417, 2014

62 Freilinger TM, "Prevalence of nonstenosing, complicated atherosclerotic plaques in cryptogenic stroke" 5 : 397-405, 2012

63 Wang Y, "Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study" 45 : 663-669, 2014

64 Jung JM, "Predictors of recurrent stroke in patients with symptomatic intracranial arterial stenosis" 43 : 2785-2787, 2012

65 Kasner SE, "Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis" 113 : 555-563, 2006

66 Fine-Edelstein JS, "Precursors of extracranial carotid atherosclerosis in the Framingham Study" 44 : 1046-1050, 1994

67 Park JH, "Post-stroke diastolic blood pressure and risk of recurrent vascular events" 24 : 1416-1423, 2017

68 Petty GW, "Population-based study of the relationship between atherosclerotic aortic debris and cerebrovascular ischemic events" 81 : 609-614, 2006

69 Tsivgoulis G, "Percutaneous transluminal angioplasty and stenting for symptomatic intracranial arterial stenosis: a systematic review and meta-analysis" 9 : 351-358, 2016

70 Al-Lamee R, "Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial" 391 : 31-40, 2018

71 Katsanos AH, "Novel oral anticoagulants for the secondary prevention of cerebral ischemia: a network metaanalysis" 9 : 359-368, 2016

72 Griffin M, "Normalisation of ultrasonic images of atherosclerotic plaques and reproducibility of grey scale median using dedicated software" 26 : 372-377, 2007

73 Coutinho JM, "Nonstenotic carotid plaque on CT angiography in patients with cryptogenic stroke" 87 : 665-672, 2016

74 Schroeder S, "Noninvasive detection and evaluation of atherosclerotic coronary plaques with multislice computed tomography" 37 : 1430-1435, 2001

75 Stary HC, "Natural history and histological classification of atherosclerotic lesions: an update" 20 : 1177-1178, 2000

76 Singh N, "Moderate carotid artery stenosis: MR imagingdepicted intraplaque hemorrhage predicts risk of cerebrovascular ischemic events in asymptomatic men" 252 : 502-508, 2009

77 Xu WH, "Middle cerebral artery intraplaque hemorrhage: prevalence and clinical relevance" 71 : 195-198, 2012

78 Chen XY, "Middle cerebral artery atherosclerosis: histological comparison between plaques associated with and not associated with infarct in a postmortem study" 25 : 74-80, 2008

79 Wu X, "Microembolic signals detected with transcranial Doppler sonography differ between symptomatic and asymptomatic middle cerebral artery stenoses in Northeast China" 9 : e88986-, 2014

80 Gao S, "Microembolic signal predicts recurrent cerebral ischemic events in acute stroke patients with middle cerebral artery stenosis" 35 : 2832-2836, 2004

81 Chan DK, "Meta-analysis of the cardiovascular benefits of intensive lipid lowering with statins" 124 : 188-195, 2011

82 Cannon CP, "Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy" 48 : 438-445, 2006

83 Abbott AL, "Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis" 40 : e573-e583, 2009

84 De Rango P, "Management of carotid stenosis in women: consensus document" 80 : 2258-2268, 2013

85 Nidorf SM, "Lowdose colchicine for secondary prevention of cardiovascular disease" 61 : 404-410, 2013

86 Rothwell PM, "Low risk of ischemic stroke in patients with reduced internal carotid artery lumen diameter distal to severe symptomatic carotid stenosis: cerebral protection due to low poststenotic flow? On behalf of the European Carotid Surgery Trialists' Collaborative Group" 31 : 622-630, 2000

87 Coward LJ, "Long-term outcome after angioplasty and stenting for symptomatic vertebral artery stenosis compared with medical treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial" 38 : 1526-1530, 2007

88 Marso SP, "Liraglutide and cardiovascular outcomes in type 2 diabetes" 375 : 311-322, 2016

89 Ovbiagele B, "Level of systolic blood pressure within the normal range and risk of recurrent stroke" 306 : 2137-2144, 2011

90 Brown DL, "Last nail in the coffin for PCI in stable angina?" 391 : 3-4, 2018

91 Louis R Caplan, "Lacunar Infarction and Small Vessel Disease: Pathology and Pathophysiology" 대한뇌졸중학회 17 (17): 2-6, 2015

92 Lee M, "Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort study" 4 : e006672-, 2014

93 Wong KS, "Intracranial stenosis in Chinese patients with acute stroke" 50 : 812-813, 1998

94 Wen-jie Yang, "Intracranial Atherosclerosis: From Microscopy to High-Resolution Magnetic Resonance Imaging" 대한뇌졸중학회 19 (19): 249-260, 2017

95 방오영, "Intracranial Atherosclerosis: Current Understanding and Perspectives" 대한뇌졸중학회 16 (16): 27-35, 2014

96 Flint AC, "Inpatient statin use predicts improved ischemic stroke discharge disposition" 78 : 1678-1683, 2012

97 Stergiopoulos K, "Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials" 172 : 312-319, 2012

98 Howard VJ, "Influence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST)" 10 : 530-537, 2011

99 Lackland DT, "Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association" 43 : 1998-2027, 2012

100 Marquardt L, "Incidence and prognosis of > or = 50% symptomatic vertebral or basilar artery stenosis: prospective population-based study" 132 : 982-988, 2009

101 Ovbiagele B, "Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis" 66 : 1344-1349, 2006

102 Khan S, "Imaging of vertebral artery stenosis: a systematic review" 78 : 1218-1225, 2007

103 Roth W, "Histopathological differences between the anterior and posterior brain arteries as a function of aging" 48 : 638-644, 2017

104 Amin-Hanjani S, "Higher stroke risk with lower blood pressure in hemodynamic vertebrobasilar disease: analysis from the VERiTAS Study" 26 : 403-410, 2017

105 Hyafil F, "High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging" 43 : 270-279, 2016

106 Harteveld AA, "High-resolution intracranial vessel wall MRI in an elderly asymptomatic population: comparison of 3T and 7T" 27 : 1585-1595, 2017

107 Amarenco P, "High-dose atorvastatin after stroke or transient ischemic attack" 355 : 549-559, 2006

108 Amin-Hanjani S, "Hemodynamic features of symptomatic vertebrobasilar disease" 46 : 1850-1856, 2015

109 Meschia JF, "Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association" 45 : 3754-3832, 2014

110 Kernan WN, "Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association" 45 : 2160-2236, 2014

111 O'Donnell MJ, "Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study" 388 : 761-775, 2016

112 D'Agostino RB Sr, "General cardiovascular risk profile for use in primary care: the Framingham Heart Study" 117 : 743-753, 2008

113 Naghavi M, "From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I" 108 : 1664-1672, 2003

114 Sarkkinen ES, "Feasibility and antihypertensive effect of replacing regular salt with mineral salt-rich in magnesium and potassium-in subjects with mildly elevated blood pressure" 10 : 88-, 2011

115 Waters MF, "Factors associated with recurrent ischemic stroke in the medical group of the SAMMPRIS trial" 73 : 308-315, 2016

116 Cannon CP, "Ezetimibe added to statin therapy after acute coronary syndromes" 372 : 2387-2397, 2015

117 Woo CH, "Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells" 102 : 538-545, 2008

118 Strazzullo P, "Excess body weight and incidence of stroke: metaanalysis of prospective studies with 2 million participants" 41 : e418-e426, 2010

119 Sabatine MS, "Evolocumab and clinical outcomes in patients with cardiovascular disease" 376 : 1713-1722, 2017

120 Meschia JF, "Evaluation and management of atherosclerotic carotid stenosis" 92 : 1144-1157, 2017

121 Palm F, "Etiology, risk factors and sex differences in ischemic stroke in the Ludwigshafen Stroke Study, a populationbased stroke registry" 33 : 69-75, 2012

122 Conroy RM, "Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project" 24 : 987-1003, 2003

123 Executive Committee for the Asymptomatic Carotid Atherosclerosis Study, "Endarterectomy for asymptomatic carotid artery stenosis" 273 : 1421-1428, 1995

124 Zinman B, "Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes" 373 : 2117-2128, 2015

125 Amarenco P, "Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial" 16 : 301-310, 2017

126 Kwon SU, "Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis" 42 : 2883-2890, 2011

127 Baigent C, "Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins" 366 : 1267-1278, 2005

128 ACCORD Study Group, "Effects of intensive bloodpressure control in type 2 diabetes mellitus" 362 : 1575-1585, 2010

129 Xie X, "Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and metaanalysis" 387 : 435-443, 2016

130 Diener HC, "Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study" 7 : 875-884, 2008

131 Mazzone T, "Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial" 296 : 2572-2581, 2006

132 Amin-Hanjani S, "Effect of hemodynamics on stroke risk in symptomatic atherosclerotic vertebrobasilar occlusive disease" 73 : 178-185, 2016

133 Baker WH, "Effect of contralateral occlusion on long-term efficacy of endarterectomy in the asymptomatic carotid atherosclerosis study (ACAS). ACAS Investigators" 31 : 2330-2334, 2000

134 Hugl B, "Effect of age and gender on restenosis after carotid endarterectomy" 20 : 602-608, 2006

135 Rantner B, "Early endarterectomy carries a lower procedural risk than early stenting in patients with symptomatic stenosis of the internal carotid artery: results from 4 randomized controlled trials" 48 : 1580-1587, 2017

136 "ECST-2. Protocol summary: version 3.10"

137 Banerjee C, "Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study" 43 : 1212-1217, 2012

138 Rozeman AD, "Duplex ultrasonography for the detection of vertebral artery stenosis: a comparison with CT angiography" 7 : e00750-, 2017

139 Jones DW, "Dual antiplatelet therapy reduces stroke but increases bleeding at the time of carotid endarterectomy" 63 : 1262-1270, 2016

140 Liu L, "Dual antiplatelet therapy in stroke and ICAS: subgroup analysis of CHANCE" 85 : 1154-1162, 2015

141 Selwaness M, "Determinants of carotid atherosclerotic plaque burden in a stroke-free population" 255 : 186-192, 2016

142 Fiorella D, "Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS)" 43 : 2682-2688, 2012

143 Kazi DS, "Cost-effectiveness of PCSK9 inhibitor therapy in patients with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease" 316 : 743-753, 2016

144 Garber AJ, "Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm: 2018 executive summary" 24 : 91-120, 2018

145 Leng X, "Computational fluid dynamics modeling of symptomatic intracranial atherosclerosis may predict risk of stroke recurrence" 9 : e97531-, 2014

146 Harloff A, "Complex plaques in the proximal descending aorta: an underestimated embolic source of stroke" 41 : 1145-1150, 2010

147 Katsanos AH, "Complex atheromatous plaques in the descending aorta and the risk of stroke: a systematic review and meta-analysis" 45 : 1764-1770, 2014

148 Chimowitz MI, "Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis" 352 : 1305-1316, 2005

149 Saam T, "Comparison of symptomatic and asymptomatic atherosclerotic carotid plaque features with in vivo MR imaging" 240 : 464-472, 2006

150 Pagidipati NJ, "Comparison of recommended eligibility for primary prevention statin therapy based on the US Preventive Services Task Force recommendations vs the ACC/AHA guidelines" 317 : 1563-1567, 2017

151 Liebeskind DS, "Collaterals dramatically alter stroke risk in intracranial atherosclerosis" 69 : 963-974, 2011

152 U.S. National Library of Medicine, "Colchicine for prevention of vascular inflammation in non-cardioembolic stroke (CONVINCE)"

153 Wang Y, "Clopidogrel with aspirin in acute minor stroke or transient ischemic attack" 369 : 11-19, 2013

154 Tsivgoulis G, "Clopidogrel load for emboli reduction in patients with symptomatic carotid stenosis undergoing urgent carotid endarterectomy" 43 : 1957-1960, 2012

155 Bhatt DL, "Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events" 354 : 1706-1717, 2006

156 Johnston SC, "Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA" 2018

157 Adams HP Jr, "Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment" 24 : 35-41, 1993

158 Kwon SU, "Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis" 36 : 782-786, 2005

159 Zhao X, "Chinese Atherosclerosis Risk Evaluation (CARE II) study: a novel cross-sectional, multicentre study of the prevalence of high-risk atherosclerotic carotid plaque in Chinese patients with ischaemic cerebrovascular events-design and rationale" 2 : 15-20, 2017

160 Gao P, "China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): a new, prospective, multicenter, randomized controlled trial in China" 21 : 196-204, 2015

161 Yamamoto Y, "Characteristics of intracranial branch atheromatous disease and its association with progressive motor deficits" 304 : 78-82, 2011

162 Sangha RS, "Challenges in the medical management of symptomatic intracranial stenosis in an urban setting" 48 : 2158-2163, 2017

163 Molina CA, "Carotid wars episode VI: return of the standard" 44 : 2959-2960, 2013

164 Calvet D, "Carotid stenting: is there an operator effect? A pooled analysis from the carotid stenting trialists' collaboration" 45 : 527-532, 2014

165 Marnane M, "Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence" 71 : 709-718, 2012

166 Biasi GM, "Carotid plaque echolucency increases the risk of stroke in carotid stenting: the Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) study" 110 : 756-762, 2004

167 Spence JD, "Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy" 33 : 2916-2922, 2002

168 U.S. National Library of Medicine, "Carotid endarterectomy versus carotid artery stenting in asymptomatic patients (ACST-2)"

169 Economopoulos KP, "Carotid artery stenting versus carotid endarterectomy: a comprehensive meta-analysis of short-term and long-term outcomes" 42 : 687-692, 2011

170 McPhee JT, "Carotid artery stenting has increased rates of postprocedure stroke, death, and resource utilization than does carotid endarterectomy in the United States, 2005" 48 : 1442-1450, 2008

171 "Canakinumab (Ilaris): Common Drug Review" Canadian Agency for Drugs and Technologies in Health

172 Neal B, "Canagliflozin and cardiovascular and renal events in type 2 diabetes" 377 : 644-657, 2017

173 Chatzikonstantinou A, "CT angiography of the aorta is superior to transesophageal echocardiography for determining stroke subtypes in patients with cryptogenic ischemic stroke" 33 : 322-328, 2012

174 Saba L, "CT and ultrasound in the study of ulcerated carotid plaque compared with surgical results: potentialities and advantages of multidetector row CT angiography" 28 : 1061-1066, 2007

175 Mott M, "CREST-2: identifying the best method of stroke prevention for carotid artery stenosis: national institute of neurological disorders and stroke organizational update" 48 : e130-e131, 2017

176 Kim BS, "Burden of intracranial atherosclerosis is associated with long-term vascular outcome in patients with ischemic stroke" 48 : 2819-2826, 2017

177 Prospective Studies Collaboration, "Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies" 373 : 1083-1096, 2009

178 SPS3 Study Group, "Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial" 382 : 507-515, 2013

179 Katsanos AH, "Blood pressure reduction and secondary stroke prevention: a systematic review and metaregression analysis of randomized clinical trials" 69 : 171-179, 2017

180 Prospective Studies Collaboration, "Blood cholesterol and vascular mortality by age, sex, and blood pressure: a metaanalysis of individual data from 61 prospective studies with 55,000 vascular deaths" 370 : 1829-1839, 2007

181 Ringleb PA, "Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events" 35 : 528-532, 2004

182 Barnett HJ, "Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators" 339 : 1415-1425, 1998

183 Amarenco P, "Atherosclerotic disease of the aortic arch and the risk of ischemic stroke" 331 : 1474-1479, 1994

184 Meissner I, "Atherosclerosis of the aorta: risk factor, risk marker, or innocent bystander? A prospective population-based transesophageal echocardiography study" 44 : 1018-1024, 2004

185 Markus HS, "Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study" 9 : 663-671, 2010

186 McGill HC Jr, "Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group" 20 : 1998-2004, 2000

187 Kelli HM, "Association between living in food deserts and cardiovascular risk" 10 : e003532-, 2017

188 Rundek T, "Association between large aortic arch atheromas and high-intensity transient signals in elderly stroke patients" 30 : 2683-2686, 1999

189 Kim DE, "Association between changes in lipid profiles and progression of symptomatic intracranial atherosclerotic stenosis: a prospective multicenter study" 43 : 1824-1830, 2012

190 ESPRIT Study Group, "Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial" 367 : 1665-1673, 2006

191 Butalia S, "Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and metaanalysis" 10 : 25-, 2011

192 Diener HC, "Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial" 364 : 331-337, 2004

193 Cohen A, "Aortic plaque morphology and vascular events: a follow-up study in patients with ischemic stroke. FAPS Investigators. French Study of Aortic Plaques in Stroke" 96 : 3838-3841, 1997

194 Ridker PM, "Antiinflammatory therapy with canakinumab for atherosclerotic disease" 377 : 1119-1131, 2017

195 Falk E, "Angina pectoris and disease progression" 92 : 2033-2035, 1995

196 Rothwell PM, "Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis" 361 : 107-116, 2003

197 Jellinger PS, "American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease" 23 (23): 1-87, 2017

198 Lewington S, "Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies" 360 : 1903-1913, 2002

199 Sharma VK, "Abstract 147: plaque inflammation is associated with early cerebral ischemic events in symptomatic carotid stenosis" 49 : A147-, 2018

200 BaerJ, "AACE and EAS lipid guidelines"

201 CAPRIE Steering Committee, "A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)" 348 : 1329-1339, 1996

202 Matsui R, "A prospective study of asymptomatic intracranial atherosclerotic stenosis in neurologically normal volunteers in a Japanese cohort" 7 : 39-, 2016

203 Mak W, "A possible explanation for the racial difference in distribution of largearterial cerebrovascular disease: ancestral European settlers evolved genetic resistance to atherosclerosis, but confined to the intracranial arteries" 65 : 637-648, 2005

204 American Diabetes Association, "9. Cardiovascular disease and risk management: standards of medical care in diabetes-2018" 41 (41): S86-S104, 2018

205 Harloff A, "3D MRI provides improved visualization and detection of aortic arch plaques compared to transesophageal echocardiography" 36 : 604-611, 2012

206 Landmesser U, "2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia" 39 : 1131-1143, 2018

207 Whelton PK, "2017 ACC/AHA/AAPA/ABC/ ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines" 71 : 1269-1324, 2018

208 Catapano AL, "2016 ESC/EAS guidelines for the management of dyslipidaemias" 37 : 2999-3058, 2016

209 Writing Committee, "2016 ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents" 68 : 92-125, 2016

210 Eckel RH, "2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines" 129 (129): S76-S99, 2014

211 Stone NJ, "2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines" 63 (63): 2889-2934, 2014

212 Goff DC Jr, "2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines" 129 (129): S49-S73, 2014

213 U.S. Department of Health and Human Services, "2008 Physical activity guidelines for Americans"

214 Halliday A, "10-Year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial" 376 : 1074-1084, 2010